Viridian Therapeutics, Inc.\DE (VRDN) Preferred Stock Liabilities (2015 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) reported Preferred Stock Liabilities of $153.95 million for Q4 2016, up 153.0% from $60.85 million a year earlier.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Preferred Stock Liabilities (2015 - 2016) Analysis & Trends
- By year, Preferred Stock Liabilities came in at $60.85 million in FY2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | - |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | - |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | - |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 2.33 Bn | -781.58 Mn | - | - |
API Access
Viridian Therapeutics, Inc.\DE Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();